Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancer
Marta Vallee Cobham, Diana DonovanWeill Cornell Breast Center, Cornell University/New York-Presbyterian Hospital, New York, NY, USAAbstract: Ixabepilone (Ixempra®; Bristol-Myers Squibb) is a novel microtubule stabilizing agent recently approved for the treatment of metastatic breast canc...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-06-01
|
| Series: | Cancer Management and Research |
| Online Access: | http://www.dovepress.com/ixabepilone-a-new-treatment-option-for-the-management-of-taxane-resist-a3309 |